117 related articles for article (PubMed ID: 17971340)
1. The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.
Wang GY; Lu CQ; Zhang RM; Hu XH; Luo ZW
Am J Epidemiol; 2008 Jan; 167(1):7-14. PubMed ID: 17971340
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.
Wang L; Wang G; Lu C; Feng B; Kang J
PLoS One; 2012; 7(7):e40219. PubMed ID: 22792244
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk.
Cattaneo F; Venesio T; Molatore S; Russo A; Fiocca R; Frattini M; Scovassi AI; Ottini L; Bertario L; Ranzani GN
Anticancer Res; 2006; 26(6B):4627-32. PubMed ID: 17201188
[TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
7. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
8. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
9. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
10. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
[TBL] [Abstract][Full Text] [Related]
11. CDH1 C-160A promoter polymorphism and gastric cancer risk.
Corso G; Berardi A; Marrelli D; Pedrazzani C; Garosi L; Pinto E; Roviello F
Eur J Cancer Prev; 2009 Feb; 18(1):46-9. PubMed ID: 19077564
[TBL] [Abstract][Full Text] [Related]
12. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
13. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer.
Lin J; Dinney CP; Grossman HB; Jhamb M; Zhu Y; Spitz MR; Wu X
Clin Genet; 2006 Sep; 70(3):240-5. PubMed ID: 16922727
[TBL] [Abstract][Full Text] [Related]
15. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
[TBL] [Abstract][Full Text] [Related]
16. Association of E-cadherin single nucleotide polymorphisms with the increased risk of endometriosis in Indian women.
Govatati S; Tangudu NK; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
Mol Hum Reprod; 2012 May; 18(5):280-7. PubMed ID: 22184339
[TBL] [Abstract][Full Text] [Related]
17. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.
Li LC; Chui RM; Sasaki M; Nakajima K; Perinchery G; Au HC; Nojima D; Carroll P; Dahiya R
Cancer Res; 2000 Feb; 60(4):873-6. PubMed ID: 10706097
[TBL] [Abstract][Full Text] [Related]
19. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
Li H; Hao X; Zhang W; Wei Q; Chen K
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
[TBL] [Abstract][Full Text] [Related]
20. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
